Alector, Inc.
NASDAQ:ALEC · NASDAQ Global Select
+$0.08 today
Vol 1.11M · Avg 0.65M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+26.81%
Period High
$3.32
Period Low
$1.14
Latest
$1.75
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Opus Genetics, Inc.
NASDAQ:IRD
$335.63M
Fate Therapeutics, Inc.
NASDAQ:FATE
$229.62M
Nkarta, Inc.
NASDAQ:NKTX
$194.96M
Molecular Partners AG
NASDAQ:MOLN
$146.29M
Acumen Pharmaceuticals, Inc.
NASDAQ:ABOS
$137.80M
PepGen Inc.
NASDAQ:PEPG
$124.85M
Corbus Pharmaceuticals Holdings, Inc.
NASDAQ:CRBP
$102.54M
Vor Biopharma Inc.
NASDAQ:VOR
$100.58M
Cassava Sciences, Inc.
SAVA
$63.77M
Applied Therapeutics, Inc.
APLT
$14.86M
What is the latest ALEC filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does ALEC have?
Intrinsic Alpha currently shows 20 recent filings for ALEC.
Explore More
Continue the stock analysis
Jump to another research area for this company.